The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness

SIMPLE SUMMARY: Approximately 80% of gastric cancer patients are diagnosed at advanced stages with an average five-year survival rate of less than 30%. Alterations of the extracellular matrix proteins have been largely demonstrated in all steps of the disease. Thus, studies for the identification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Filipe, Santos-Ferreira, Liliana, Pinto, Marta T., Gomes, Catarina, Reis, Celso A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001774/
https://www.ncbi.nlm.nih.gov/pubmed/33809543
http://dx.doi.org/10.3390/cancers13061330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001774/
https://www.ncbi.nlm.nih.gov/pubmed/33809543
http://dx.doi.org/10.3390/cancers13061330

Ejemplares similares